The US Food & Drug Administration (US FDA) has given final approval for Aurobindo
Pharma Ltd. for the abbreviated new drug application (ANDA) for famciclovir
tablets 125mg, 250mg and 500mg.
Famciclovir tablet is the generic version of Novartis Pharmaceuticals and is
indicated for the treatment of recurrent mucocutaneous herpes simplex
infections in HIV-infected patients and also for suppression of recurrent
genital herpes in immunocompetent patients.
The Aurobindo Pharma Ltd. now has a total of 132 ANDA approvals from US FDA.